“Coming together is a beginning, staying together is progress, and working together is success.” Henry Ford
Azar Azad, Co-founder and CEO
Azar Azad is a serial entrepreneur, received her doctorate degree in clinical Diagnostic Laboratory Sciences, followed by her Ph.D. in clinical biochemistry. Azar has over 20 years experiences in clinical research and diagnostic area, she has been principal investigator, co-principle investigator, and collaborator in multiple national clinical trials; developing and implemented clinical trials (phase I-III) for pharma and biotech industry; operated projects for validation and regulatory submission for multiple medical devices,platforms and analytical assays with track record of achieving FDA and HealthCanada approvals. She is certified Lean Six Sigma Black Belt and ISO auditor for medical devices.
Trevor McKee, Co-founder and CSO
Dr. Trevor McKee received his Ph.D. from MIT in 2005 and is an accomplished biomedical engineer who has published 35 peer-reviewed papers in the fields of biomedical imaging and image analysis methods. Over the past 5 years he has successfully managed the STTARR image analysis core facility,developing multi-modality image analysis methods for academic and industryclients. He serves as Chief Scientific Officer for A.I. VALI and is a keyopinion leader in IMC analysis and in the application of imaging methods tomeasure drug and oxygen transport.
Justin Grant, Co-founder
Dr. Justin Grant achieved a Ph.D. in Pharmaceutical Sciences from the Leslie Dan Faculty of Pharmacy and an Executive MBA from the Rotman School of Management at the University of Toronto. Over the past 10 years, Justin held academic Faculty appointments, managed large cancer research grants and a world-renowned preclinical imaging facility known as the STTARR InnovationCentre at Princess Margaret Cancer Centre. He is well known for providing advisory in science and business as well as establishing partnerships and collaborations with Academics, Pharma, Biotech and Medical Device companies.
Sassan Azad, Medical Science Liaison
Sassan Azad is an experienced Certified Clinical Research Professional (CCRP), who received his M.Sc. in Clinical Biochemistry from Iran University of Medical Sciences, as well as a certification in Clinical Epidemiology from Dalla Lana School of Public Health at the University of Toronto. His role as Medical Science Liaison (MSL) is to establish and maintain relationships with KOLs in both Pharma/Biotech and Academia, focusing on A.I. clinical applications.
Andrzej Cholewinski, Ph.D. , Sr. Project Manager/Application Scientist Image Analysis
Andrzej Cholewinski received his Ph.D. in Biochemistry from Imperial College, London and has numerous publications in the fields of second messenger biology, calcium imaging and image analysis. He has over 25 years of experience in the Life Sciences, both in academia and the pharmaceutical / biotechnology sector with over 12 years spent at Definiens as a Sr. Program Manager / Application Scientist. He has been involved in image analysis applications and development in prior positions with Imaging Research Inc., Amersham Biosciences, and GE. Andrzej’s expertise lies in automated microscopy, scanner technologies and in tissue and cellular image analysis with a focus on immuno-oncology, the tumour micro-environment and biomarker profiling.
Allen Wazny, CPA/CA, Financial Adviser
Allen Wazny is a Canadian CPA/CA that recently relocated back to Calgary, Canada after nearly 18 years working in various senior finance roles in Kazakhstan, Russia, Dubai and Doha. In 2017, Allen started researching emerging technologies which lead to advisory roles with Blockchain startups Uncloak (UK) and Digipharm (Switzerland); social impact startup, Pocket Money (Singapore); and innovative forestry startup, TimberWise Group (Canada)